Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

AKEBIA THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where AKEBIA THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $67.99M came in.
  • Fiscal year ended 2025-12-31: from investing, $7.93M went out.
  • Fiscal year ended 2025-12-31: from financing, $72.93M came in.
  • Fiscal year ended 2025-12-31: change in cash, $132.99M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31$67.99M-$7.93M-$462.00K$10.00M$1.68M$61.70M*$132.99M
2024-12-31-$40.66M-$33.00K-$37.10M$45.00M$385.00K$41.38M*$8.97M
2023-12-31-$23.38M$0.00-$32.00M$0.00$1.00K$6.79M*-$48.59M
2022-12-31-$73.15M-$114.00K$0.00$67.00K$14.53M*-$58.67M
2021-12-31-$252.97M$39.94M$0.00$0.00$133.73M*-$79.29M
2020-12-31-$110.39M-$40.00M$19.98M$1.23M$210.52M*$81.33M
2019-12-31-$257.44M$211.18M$77.67M$560.00K$10.74M*$42.70M
2018-12-31-$97.49M$36.59M$0.00$647.00K$95.92M*$35.66M
2017-12-31-$56.16M-$177.26M$1.31M$114.93M*-$117.18M
2016-12-31$57.91M$12.71M$124.00K$66.82M*$137.56M
2015-12-31-$52.41M-$13.69M$130.00K$82.96M*$17.00M
2014-12-31-$27.48M-$65.35M-$162.00K$104.33M$11.56M
2013-12-31-$11.33M-$11.43M$5.00K$42.33M*$19.57M
2012-12-31-$7.21M$1.37M$2.48M*-$3.37M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30$3.52M*-$4.08M*$0.00*$0.00*$85.00K*-$6.62M*
2026-03-31-$21.21M-$62.00K$0.00$0.00$20.00K-$946.00K*-$22.20M
2025-12-31$31.13M*-$7.88M*$0.00*$0.00*$63.00K*-$4.91M*
2025-09-30$28.11M*-$77.00K*$0.00*$0.00*$961.00K*
2025-06-30$22.34M*-$126.00K*$0.00*$0.00*$178.00K*$1.54M*
2025-03-31-$13.59M$154.00K-$462.00K$10.00M$482.00K$64.92M*$61.51M
2024-12-31-$4.47M*-$2.00K*$1.00K*$0.00*$230.00K*$22.09M*
2024-09-30-$6.70M*-$2.00K*$0.00*$0.00*$0.00*$1.22M*
2024-06-30-$10.07M*-$29.00K*-$374.00K*$8.00M*$14.00K*
2024-03-31-$19.43M$0.00-$36.73M$37.00M$141.00K$18.06M*-$957.00K
2023-12-31-$2.31M*$0.00*-$8.00M*$0.00*$1.00K*$6.71M*
2023-09-30-$7.17M*$0.00*$0.00*$0.00*$0.00*
2023-06-30$3.63M*$0.00*-$8.00M*$0.00*$0.00*
2023-03-31-$17.54M$0.00-$16.00M$0.00$0.00-$33.50M
2022-12-31-$54.68M*$0.00*$0.00*
2022-09-30$33.80M*$0.00*-$33.00M*$0.00*
2022-06-30-$30.66M*$0.00*$0.00*$67.00K*
2022-03-31-$21.62M-$114.00K$0.00$367.00K$47.18M*$25.81M
2021-12-31-$62.81M*$0.00*$0.00*$5.40M*
2021-09-30-$56.27M*$0.00*$0.00*$16.48M*
2021-06-30-$63.14M*$20.00M*$0.00*$37.37M*
2021-03-31-$70.75M$19.94M$0.00$74.48M*$23.67M
2020-12-31-$30.78M*$59.68M*$0.00*$30.51M*
2020-09-30-$27.24M*-$49.94M*$405.00K*$649.00K*
2020-06-30$37.22M*-$49.99M*$409.00K*$142.40M*
2020-03-31-$89.59M$245.00K$412.00K$56.94M*-$32.00M
2019-12-31-$92.14M*$22.28M*$0.00*$94.42M*
2019-09-30$10.99M*$24.39M*$0.00*
2019-06-30-$38.37M*$54.03M*$195.00K*$8.61M*
2019-03-31-$137.93M$110.47M$365.00K-$14.81M*-$41.90M
2018-12-31-$73.70M*$16.72M*$92.00K*
2018-09-30-$12.46M*$11.01M*$58.00K*
2018-06-30$9.00M*-$3.57M*$314.00K*
2018-03-31-$20.33M$12.43M$183.00K$95.73M*$88.02M
2017-12-31-$16.38M*-$8.31M*$204.00K*$5.04M*-$19.44M*
2017-09-30-$54.62M*-$44.96M*$930.00K*$62.85M*-$35.79M*
2017-06-30$24.36M*-$31.69M*$110.00K*$45.36M*$38.14M*
2017-03-31-$9.53M-$92.30M$68.00K$1.68M*-$100.08M
2016-12-31$95.67M*$22.31M*-$1.00K*$3.53M*$121.50M*
2016-09-30-$28.24M*$45.57M*$5.00K*$2.32M*$19.65M*
2016-06-30-$26.95M*$29.79M*$101.00K*$2.74M*
2016-03-31$17.43M-$84.95M$19.00K$61.16M*-$6.34M
2015-12-31-$22.91M*$1.64M*$60.00K*$4.28M*-$16.93M*
2015-09-30-$9.03M*-$14.46M*-$3.00K*$13.95M*-$9.54M*
2015-06-30-$12.12M*-$4.28M*$59.00K*$64.69M*$48.36M*
2015-03-31-$8.35M$3.40M$50.00K-$4.89M
2014-12-31-$9.20M*-$7.64M*-$83.00K*$35.00K*-$16.89M*
2014-09-30-$5.60M*-$40.00M*-$58.00K*-$10.66M*-$45.73M*
2014-06-30-$6.67M*-$23.07M*$911.00*-$1.18M*-$30.93M*
2014-03-31-$6.01M$5.36M$114.95M-$9.20M*$105.10M
2013-12-31-$4.91M*$1.74M*-$3.39M*
2013-09-30-$2.94M*-$16.14M*
2013-06-30-$1.96M*$40.10M*$38.15M*
2013-03-31-$1.53M$2.48M*$953.08K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33